Navigation Links
Mortality Data Presented for Patients Treated with Effient® Who Underwent Isolated Coronary Artery Bypass Surgery
Date:11/16/2010

age=Quote&Ticker=LLY"> LLY) co-developed Effient, an oral antiplatelet agent discovered by Daiichi Sankyo and its Japanese research partner, Ube Industries, Ltd. Effient helps keep blood platelets from clumping together and developing a blockage in an artery. Effient is approved by the U.S. Food and Drug Administration for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with ACS who are managed with an artery-opening procedure known as PCI. PCI usually includes the placement of a stent to help keep the artery open.

About Acute Coronary SyndromesACS, which includes heart attack and unstable angina (chest pain), affects more than 1.5 million people in the United States annually, many of whom are managed with PCI.(5) In 2010, an estimated 785,000 people in the United States will have a new heart attack, and about 470,000 will have a recurrent attack.(6) ACS results in significant morbidity and mortality, accounting for half of all deaths due to cardiovascular disease, and costs Americans more than $150 billion annually, nearly 60 percent of which results from rehospitalization.(7)

Important Safety Information about Effient Antiplatelet medicines, including Effient, can increase a patient's risk of bleeding. If patients have unexplained or excessive bleeding while on Effient, they should contact their doctor right away as some bleeding can be serious, and sometimes may lead to death. Patients should not take Effient if they have a stomach ulcer or other conditions that cause bleeding or if they have a history of stroke or “mini-stroke” (transient ischemic attack or TIA).If patients are 75 or older, or if they weigh less than 132 pounds, or if they are taking anticoagulants (e.g., warfarin) or taking NSAIDs (e.g., ibuprofen or naproxen) for a long time, they should talk to their doctor, as they may be at an increased risk of bleeding.Patients should not stop taking Effient without first talki
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Study Shows Use of AdvanDxs PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections
2. n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure
3. Preliminary Data From Experimental Study Demonstrate Increased Mortality in Stroke Patients Treated With Epoetin Alfa
4. Unemployment, Health Care Spending Affect Mortality
5. Increased Mortality Associated With Nocturia
6. Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery
7. Analysis Shows Novartis Drug TOBI® Associated With Reduced Mortality in Cystic Fibrosis Patients With Common Lung Infection
8. Robotic Prostatectomy Expert Dr. David Samadi Talks About Big Strides in the Fight Against Prostate Cancer - Mortality Rate Declines 45%
9. Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows
10. Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Surgery
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015 For the past 15 ... accidents per year in the U.S. alone (U.S. Census Bureau 2012). ... are minor fender benders BUT there are quite a few where ... cabin intrusion, which can obstruct the seatbelt release button or occupant ... being in any serious accidents in their lifetime but may still ...
(Date:3/2/2015)... Following announcements from both Novartis and ... Inc. (NASDAQ:  ARRY) today announced the completion of ... Novartis.  Along with global ownership of both assets, ... million from Novartis. Ron Squarer, Chief ... the Novartis-GSK transaction, Array now owns both binimetinib ...
(Date:3/2/2015)... , March 2, 2015 Leading patient ... kicking off the 2015 One Million Strong ... national campaign will raise awareness and funds for colorectal ... than one million colorectal cancer survivors living in ... disease with great strength and courage every day. ...
Breaking Medicine Technology:New SuperVizor, an Automobile Escape Tool, Ensures the Safety of Drivers and Passengers on the Road 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 3Array Announces Completion Of Binimetinib And Encorafenib Transactions 4Array Announces Completion Of Binimetinib And Encorafenib Transactions 5Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 2Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 3Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 4Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 5
... Tolerx, Inc. and GlaxoSmithKline (GSK) today ... an investigational humanized anti-CD3 monoclonal antibody, did not meet ... month 12 in patients with new-onset autoimmune type 1 ... data, no new or unexpected treatment-related safety concerns have ...
... MATEO, Calif., March 11, 2011 Sonitus Medical, Inc., ... non-surgical and removable hearing prosthetic to transmit sound via ... Mark certification for its SoundBite Hearing System. The company ... Assurance System Approval. This is the first European regulatory ...
Cached Medicine Technology:Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint 2Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint 3Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint 4Sonitus Medical Receives European CE Mark for SoundBite™ Hearing System 2
(Date:3/2/2015)... (PRWEB) March 02, 2015 Ticket Down ... at the Hollywood Bowl . This popular site has ... appreciation promo code JIMMY-BUFFETT-2015 for added savings. , Parrotheads ... favorite performer will be headlining at the Hollywood Bowl ... will be on Thursday, October 22nd and it will ...
(Date:3/2/2015)... 02, 2015 Doctors in Novara, Italy ... better predictor of outcomes for people with mesothelioma than ... of the new study on the Surviving Mesothelioma ... University of Eastern Piedmont followed the cases of 172 ... for excess lung fluid. , “Persistent lung expansion ...
(Date:3/2/2015)... March 02, 2015 Burns Engineering's ... calibration for Secondary Standard Platinum Resistance Thermometers (SSPRTs) ... business days or less . . . guaranteed. ... ® Accredited (Lab Code 200706-0), ISO 9001 and ... Temperature range is -196°C to 500°C, both ITS-90 ...
(Date:3/2/2015)... 02, 2015 The minimally invasive ... a CAGR of 6.1% to reach $14,133.0 million ... , Factors such as advantages of minimally invasive ... owing to minimally invasive surgeries and increasing number ... driving the global minimally invasive surgical instruments market. ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Four Seasons Resort ... celebrating its 25th anniversary this year, having officially opened its ... the luxury resort is honoring over 70 employees who started ... -- from amongst the approximately 400 original employees. The ... Resort’s Oceanfront Lawn. , This Four Seasons flagship ...
Breaking Medicine News(10 mins):Health News:Cheap Jimmy Buffett Tickets Hollywood Bowl: Ticket Down Slashes Prices on Jimmy Buffett Tickets at the Hollywood Bowl in Los Angeles/Hollywood, CA 2Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2
... ANN ARBOR, Mich. A mutant protein found in nearly ... cancer,s development but in its continued growth, according to a ... The finding suggests a possible target for developing new ways ... mutations in the Kras gene are what cause pancreatic cancer ...
... largest studies to investigate lumbar spine disc degeneration found ... more likely to have disc degeneration than those with ... resonance imaging (MRI) show elevated BMI is associated with ... greater severity of disc degeneration, including narrowing of the ...
... Jan. 28 (HealthDay News) -- For some people a change in ... depression, according to an expert who describes how to cope with ... ambient light, said Dr. Dan Iosifescu, director of the Mount Sinai ... "A gland in our brain provides a time signal, based on ...
... , FRIDAY, Jan. 27 (HealthDay News) -- Eating a high-fiber ... a low-fiber diet might, according to a new study that ... a disease of the intestines in which pouches develop in ... Carolina School of Medicine analyzed data from more than 2,100 ...
... 2012 Researchers at UT Southwestern Medical Center have developed ... a new imaging technique to diagnose brain tumors. The unique ... tumors are located in areas of the brain too dangerous ... provides a definitive diagnosis of cancer based on imaging of ...
... News) -- Positive reinforcement, such as receiving small, unexpected ... to help patients with high blood pressure take their ... black Americans. The findings are significant because poor ... death, the researchers from the Center for Healthful Behavior ...
Cached Medicine News:Health News:Gene linked to pancreatic cancer growth, U-M study finds 2Health News:Lumbar disc degeneration more likely in overweight and obese adults 2Health News:Lumbar disc degeneration more likely in overweight and obese adults 3Health News:Winter Doldrums Got You Down? Here's How to Bounce Back 2Health News:Common Gastro Disease Occurs Even With High-Fiber Diet 2Health News:Diagnostic brain tumor test could revolutionize care of patients 2Health News:Positive Reinforcement May Help Patients Take Their Meds 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: